CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 5 of 6

Scandinavian Journal of Rheumatology

Briefs 161–200 of 212 CurrentRheuma has covered from this journal, newest publication first

Latest from Scandinavian Journal of Rheumatology

All coverage, newest first

  1. Scand J Rheumatol

    Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland

    Cohort studySpondyloarthritis & PsA

  2. Scand J Rheumatol

    Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic

    Cohort studyFibromyalgia & pain

  3. Scand J Rheumatol

    Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

    Cohort studySpondyloarthritis & PsA

  4. Scand J Rheumatol

    Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial

    Randomized controlled trialAcross diseases

  5. Scand J Rheumatol

    Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines

    Cohort studyGout & crystals

  6. Scand J Rheumatol

    Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study

    Secondary analysisRA

  7. Scand J Rheumatol

    Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis

    Research articleRA

  8. Scand J Rheumatol

    The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development

    Cohort studyRA

  9. Scand J Rheumatol

    Impact of triage by a rheumatologist on appropriateness of referrals from primary to secondary care: a cluster randomized trial

    Randomized controlled trialAcross diseases

  10. Scand J Rheumatol

    Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  11. Scand J Rheumatol

    Therapy satisfaction and health literacy are key factors to improve medication adherence in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  12. Scand J Rheumatol

    The validity of the Danish version of the Fibromyalgia Impact Questionnaire – Revised applied in a clinical setting: a Rasch analysis

    Diagnostic or prognostic studyFibromyalgia & pain

  13. Scand J Rheumatol

    Kinetics of response to iloprost evaluated by laser speckle contrast analysis in systemic sclerosis

    Cohort studySystemic sclerosis

  14. Scand J Rheumatol

    Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort

    Cohort studyAcross diseases

  15. Scand J Rheumatol

    Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial

    Secondary analysisRA

  16. Scand J Rheumatol

    Patients with laboratory criteria of anti-phospholipid syndrome and ‘non-criteria’ manifestations: a multicenter cohort

    Cohort studyLupus & APS

  17. Scand J Rheumatol

    How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort

    Cross-sectional studySpondyloarthritis & PsA

  18. Scand J Rheumatol

    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study

    Research articleRA

  19. Scand J Rheumatol

    Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register

    Diagnostic or prognostic studySpondyloarthritis & PsA

  20. Scand J Rheumatol

    Impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data

    Cross-sectional studyOsteoarthritis

  21. Scand J Rheumatol

    Ultrasound centre frequency shifts as a novel approach for diagnosing giant cell arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  22. Scand J Rheumatol

    Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland

    Case-control studyAcross diseases

  23. Scand J Rheumatol

    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre

    Cohort studyRA

  24. Scand J Rheumatol

    Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial

    Randomized controlled trialSpondyloarthritis & PsA

  25. Scand J Rheumatol

    The validity of systemic sclerosis diagnoses in two university hospitals in Finland

    Diagnostic or prognostic studySystemic sclerosis

  26. Scand J Rheumatol

    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

    Cohort studyRA

  27. Scand J Rheumatol

    Corticosteroids reduce vascular ultrasound sensitivity in fast- track pathways (FTP): results from Coventry Multi-Disciplinary FTP for cranial Giant Cell Arteritis

    Cohort studyVasculitis & PMR

  28. Scand J Rheumatol

    Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis

    Cohort studyVasculitis & PMR

  29. Scand J Rheumatol

    Pentraxin-3 – a potential biomarker in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  30. Scand J Rheumatol

    Pain extent is associated with Central Sensitization Inventory but not widespread pressure pain sensitivity or psychological variables in women with fibromyalgia

    Cross-sectional studyFibromyalgia & pain

  31. Scand J Rheumatol

    Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

    Cross-sectional studySpondyloarthritis & PsA

  32. Scand J Rheumatol

    NT-proBNP and sRAGE levels in early rheumatoid arthritis

    Cohort studyRA

  33. Scand J Rheumatol

    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017

    Cohort studyRA

  34. Scand J Rheumatol

    Monocyte secretory profiling in a clinical and MEFV genotype-characterized cohort of Danish familial Mediterranean fever patients: diagnostic potential of CCL1 and CXCL1.

    Cross-sectional studyAutoinflammatory & rare

  35. Scand J Rheumatol

    Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial

    Randomized controlled trialAcross diseases

  36. Scand J Rheumatol

    Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination

    Cohort studyAcross diseases

  37. Scand J Rheumatol

    Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres

    Cohort studySjögren's & overlap

  38. Scand J Rheumatol

    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial

    Randomized controlled trialRA

  39. Scand J Rheumatol

    Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy

    Cross-sectional studySpondyloarthritis & PsA

  40. Scand J Rheumatol

    Serum CCL28 as a biomarker for diagnosis and evaluation of Sjögren’s syndrome

    Cross-sectional studySjögren's & overlap

All 212 Briefs in ExploreShowing Briefs 161–200 of 212, newest first